The purpose of this study is to evaluate the efficacy of Cipros 10 association in the treatment of Dyslipidemia Treatment
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
146
oral, once a day.
oral, once a day.
Allergisa
Campinas, São Paulo, Brazil
Reduction of serum triglyceride levels measured between the first visit and last visit.
Time frame: 12 weeks
Incidence and severity of adverse events recorded during the study.
Time frame: 13 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.